The window of greatest vulnerability to chemical carcinogens may begin before birth — a finding that fundamentally reshapes how researchers think about breast and gynecological cancer prevention. Decades of assumed adult-only exposure risk are now being challenged by mechanistic and epidemiological evidence pointing squarely at prenatal and early developmental life stages as the periods when endocrine-disrupting chemicals (EDCs) do their most lasting damage.
This narrative review, drawing on PubMed, Embase, Scopus, and Cochrane literature through April 2026 and appraised using GRADE, AMSTAR-2, and the Newcastle-Ottawa Scale, synthesizes evidence across five major EDC classes: bisphenol compounds, phthalates, polychlorinated biphenyls (PCBs), organochlorine pesticides, and PFAS. Across breast, endometrial, ovarian, and cervical cancers, the mechanistic fingerprints are consistent — estrogen receptor modulation, epigenetic reprogramming, oxidative stress induction, and oncogenic pathway disruption. The headline finding is that prenatal and early-life DDT/DDE exposure correlates with up to a 3.7-fold increased breast cancer risk — a striking magnitude rarely observed in environmental epidemiology. Endometrial cancer adds a further complexity: xenoestrogen mixtures exhibit non-monotonic dose-response curves, meaning risk does not scale linearly with dose, which undermines standard regulatory toxicology models that assume linear relationships.
Placing this review in context, the non-monotonic dose-response phenomenon has been contentious in regulatory science for over two decades, yet it continues gaining empirical support, particularly for hormone-mimicking compounds. If confirmed across populations, it has profound implications: conventional 'safe threshold' frameworks used to set exposure limits may systematically underestimate risk at low environmental doses. The prenatal exposure window finding aligns with the developmental origins of health and disease (DOHaD) framework, which has been building momentum since the 1990s. Critically, this is a narrative review — not a meta-analysis — so pooled quantitative estimates are absent, and the observational nature of constituent studies cannot establish causality. Ovarian and cervical cancer associations remain preliminary. Still, the breadth of EDC classes implicated, the consistency of mechanisms across cancer types, and the high-quality evidence appraisal tools applied make this a meaningful synthesis for clinicians and researchers tracking environmental oncology.